Key result
Acute autonomic modulation via atrial pacing increased QT variability in heart failure patients compared to subjects with normal hearts.
Why the study?
Does acute autonomic nervous system modulation affect QT variability in heart failure patients prone to ventricular tachycardia?
Observational (n=29)
Does acute autonomic nervous system modulation affect QT variability in heart failure patients prone to ventricular tachycardia?
Heart failure patients with spontaneous ventricular tachycardia exhibit increased QT variability that is not solely driven by heart rate variation and is relatively resistant to acute autonomic modulation.
Answers are grounded in this paper and cite their sources.
Highlights potential autonomic contribution to repolarization instability in heart failure; leaves open therapeutic implications pending longitudinal data.
QT variability (QTV) signifies repolarization lability, and increased QTV is a risk predictor for sudden cardiac death. The aim of the present study was to investigate the role of autonomic nervous system activity on QTV. This study was performed in 29 subjects: 10 heart failure (HF) patients with spontaneous ventricular tachycardia [HFVT(+)], 10 HF patients without spontaneous VT [HFVT(-)], and 9 subjects with structurally normal hearts (HNorm). The beat-to-beat QT interval was measured on 3-min records of surface ECGs at baseline and during interventions (atrial pacing and esmolol, isoprenaline, and atropine infusion). Variability in QT intervals was expressed as the SD of all QT intervals (SDQT). The ratio of the SDQT to SD of RR intervals (SDRR) was calculated as an index of QTV normalized to heart rate variability. There was a trend toward a higher baseline SDQT-to-SDRR ratio in the HFVT(+) group compared with the HFVT(-) and HNorm groups (P = 0.09). SDQT increased significantly in the HFVT(+) and HFVT(-) groups compared with the HNorm group during fixed-rate atrial pacing (P = 0.008). Compared with baseline, isoprenaline infusion increased SDQT in HNorm subjects (P = 0.02) but not in HF patients. SDQT remained elevated in the HFVT(+) group relative to the HNorm group despite acute β-adrenoceptor blockade with esmolol (P = 0.02). In conclusion, patients with HF and spontaneous VT have larger fluctuations in beat-to-beat QT intervals. This appears to be a genuine effect that is not solely a consequence of heart rate variation. The effect of acute autonomic nervous system modulation on QTV appears to be limited in HF patients.
No takes yet. Share an insight, caveat, or question.
Nayyar et al. (2013) conducted an observational in Heart failure prone to ventricular tachycardia (n=29). Atrial pacing, esmolol, isoprenaline, and atropine infusion vs. Baseline and subjects with structurally normal hearts was evaluated on QT variability (SDQT and SDQT-to-SDRR ratio). Acute autonomic modulation via atrial pacing increased QT variability in heart failure patients compared to subjects with normal hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: